Instituto de Parasitología y Biomedicina López Neyra -ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2021

  1. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

    Nature Communications, Vol. 12, Núm. 1

  2. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085

  3. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

    Scientific Reports, Vol. 11, Núm. 1

2015

  1. Differential phenotypic and functional profiles of TcCA-2-specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in chagasic patients

    PLoS ONE, Vol. 10, Núm. 3

2014

  1. The innate immune response status correlates with a divergent clinical course in congenital Chagas disease of twins born in a non-endemic country

    Acta Tropica, Vol. 140, pp. 84-90

2013

  1. Benznidazole treatment reduces the induction of indoleamine 2,3-dioxygenase (IDO) enzymatic activity in Chagas disease symptomatic patients

    Parasite Immunology, Vol. 35, Núm. 5-6, pp. 180-187

2012

  1. Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology

    Clinical and Vaccine Immunology, Vol. 19, Núm. 2, pp. 167-173

  2. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8+ T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients

    Molecular Immunology, Vol. 52, Núm. 3-4, pp. 289-298

2011

  1. Identification of HLA-A*02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients

    Microbes and Infection, Vol. 13, Núm. 12-13, pp. 1025-1032

  2. Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markers

    BMC Infectious Diseases, Vol. 11

2010

  1. Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo

    Blood, Vol. 115, Núm. 22, pp. 4412-4420

2006

  1. Marcadores inmunológicos en la enfermedad de Chagas

    Enfermedades Emergentes, Vol. 8, Núm. SUPPL. 1, pp. 20-21

2003

  1. Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice

    Clinical and Experimental Immunology, Vol. 131, Núm. 1, pp. 41-47

2002

  1. Trypanosoma cruzi heat-shock protein-70 kDa, alone or fused to the parasite KMP11 antigen, induces functional maturation of murine dendritic cells

    Immunology and Cell Biology, Vol. 80, Núm. 3, pp. 241-247

2001

  1. Mapping of the antigenic determinants of the T. Cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera

    Clinical and Experimental Immunology, Vol. 123, Núm. 3, pp. 465-471

2000

  1. HSP70 from Trypanosoma cruzi is endowed with specific cell proliferation potential leading to apoptosis

    International Immunology, Vol. 12, Núm. 12, pp. 1685-1693

  2. Plasticity of the histone H2A genes in a Brazilian and six Colombian strains of Trypanosoma cruzi

    Acta Tropica, Vol. 75, Núm. 2, pp. 203-210

  3. The stability and maturation of the H2A histone mRNAs from Trypanosoma cruzi are implicated in their post-transcriptional regulation

    Biochimica et Biophysica Acta - Gene Structure and Expression, Vol. 1490, Núm. 1-2, pp. 1-10

1999

  1. Phage recovery by electroporation of naked DNA into host cells avoids the use of packaging extracts

    Analytical Biochemistry, Vol. 267, Núm. 1, pp. 234-235

1998

  1. Control mechanisms of the H2A genes expression in Trypanosoma cruzi

    Molecular and Biochemical Parasitology, Vol. 92, Núm. 2